Array Technologies
ARRY
NZ$11.81
Share price
2.03%
Change (1 day)
-34.97%
Change (1 year)
Categories
Revenue for Array Technologies (ARRY)
Revenue in 2025 (TTM): NZ$1.80 Billion
According to Array Technologies's latest financial reports the company's current revenue (TTM 
) is NZ$1.78 Billion. In 2024 the company made a revenue of NZ$1.62 Billion a decrease over the revenue in the year 2023 that were of NZ$2.49 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Array Technologies from 2020 to 2025
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2025 (TTM) | NZ$1.80 B | 11.17% |
| 2024 | NZ$1.62 B | -34.86% |
| 2023 | NZ$2.49 B | -3.34% |
| 2022 | NZ$2.57 B | 108.25% |
| 2021 | NZ$1.23 B | 2.4% |
| 2020 | NZ$1.20 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | NZ$57.14 B | 3,105.02% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | NZ$0.37 M | -99.98% | 🇺🇸 USA |
 Novartis NVS | NZ$89.12 B | 4,898.46% | 🇨🇭 Switzerland |
 Eli Lilly LLY | NZ$82.05 B | 4,502.25% | 🇺🇸 USA |
 AstraZeneca AZN | NZ$92.06 B | 5,063.76% | 🇬🇧 UK |